66 related articles for article (PubMed ID: 12580846)
21. Prospective and randomised public-health trial on neural network-assisted screening for cervical cancer in Finland: results of the first year.
Nieminen P; Hakama M; Viikki M; Tarkkanen J; Anttila A
Int J Cancer; 2003 Jan; 103(3):422-6. PubMed ID: 12471627
[TBL] [Abstract][Full Text] [Related]
22. Low proportion of false-negative smears in the Finnish program for cervical cancer screening.
Lönnberg S; Anttila A; Kotaniemi-Talonen L; Kujari H; Melkko J; Granroth G; Vornanen M; Pietiläinen T; Sankila A; Arola J; Luostarinen T; Nieminen P
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):381-7. PubMed ID: 20142239
[TBL] [Abstract][Full Text] [Related]
23. Cervix cancer screening in Croatia within the European Cervical Cancer Prevention Week.
Skopljanac-Macina L; Mahovlić V; Ovanin-Rakić A; Barisić A; Rajhvajn S; Juric D; Babić D; Corusić A; Oresković S
Coll Antropol; 2010 Jun; 34(2):613-7. PubMed ID: 20698138
[TBL] [Abstract][Full Text] [Related]
24. Current challenges in cancer screening. Part III. Cervical cancer screening: can we do better?
Bressler J
Dis Mon; 2000 Jun; 46(6):405-20. PubMed ID: 10909861
[No Abstract] [Full Text] [Related]
25. Population-based organized cervical cancer screening pilot program in France.
Hamers FF; Duport N; Beltzer N
Eur J Cancer Prev; 2018 Sep; 27(5):486-492. PubMed ID: 28362653
[TBL] [Abstract][Full Text] [Related]
26. Birth outcomes following treatment for precancerous changes to the cervix: a population-based record linkage study.
Reilly R; Paranjothy S; Beer H; Brooks CJ; Fielder HM; Lyons RA
BJOG; 2012 Jan; 119(2):236-44. PubMed ID: 21790951
[TBL] [Abstract][Full Text] [Related]
27. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
[TBL] [Abstract][Full Text] [Related]
28. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
[TBL] [Abstract][Full Text] [Related]
29. [Organized cervical cancer screening for underpriviledged women].
Piana L; Leandri FX; Jacqueme B; Heid P; Corti J; Andrac-Meyer L; Sancho-Garnier H
Bull Cancer; 2007 May; 94(5):461-7. PubMed ID: 17535784
[TBL] [Abstract][Full Text] [Related]
30. Comparison of a self-administered tampon ThinPrep test with conventional pap smears for cervical cytology.
Budge M; Halford J; Haran M; Mein J; Wright G
Aust N Z J Obstet Gynaecol; 2005 Jun; 45(3):215-9. PubMed ID: 15904447
[TBL] [Abstract][Full Text] [Related]
31. Cytological screening for precancerous lesions of the cervix.
Sng I
Singapore Med J; 1987 Oct; 28(5):415-21. PubMed ID: 3433107
[No Abstract] [Full Text] [Related]
32. Screening for cervical cancer with the human papillomavirus test in an area of central Italy with no previous active cytological screening programme.
Confortini M; Giorgi Rossi P; Barbarino P; Passarelli AM; Orzella L; Tufi MC
J Med Screen; 2010; 17(2):79-86. PubMed ID: 20660436
[TBL] [Abstract][Full Text] [Related]
33. Management of abnormal pap smear--consensus guidelines of the National Cervical Cancer Screening Programme in Poland Coordinating Centre, the Polish Gynaecological Society, the Polish Society of Pathologists, and Polish Society of Colposcopy and Uterine Cervix Pathology.
; ; ;
Ginekol Pol; 2009 Feb; 80(2):129-38. PubMed ID: 19338211
[No Abstract] [Full Text] [Related]
34. [The clarification of a suspect cervical smear--are dysplasia units needed?].
Heinzl S
Gynakol Geburtshilfliche Rundsch; 2004 Jun; 44(3):138-41. PubMed ID: 15211059
[TBL] [Abstract][Full Text] [Related]
35. Quality control assurance in national screening programmes for cervical cancer.
Hadwin RJ; Walker PG
Ann Acad Med Singap; 2003 Sep; 32(5):632-7. PubMed ID: 14626791
[TBL] [Abstract][Full Text] [Related]
36. Cervical cancer screening programme in Primorsko-Goranska County, Croatia--the results of the pilot study.
Vrdoljak-Mozetic D; Ostojić DV; Stemberger-Papić S; Janković S; Glibotić-Kresina H; Brncić-Fischer A; Benić-Salamon K
Coll Antropol; 2010 Mar; 34(1):225-32. PubMed ID: 20437641
[TBL] [Abstract][Full Text] [Related]
37. Rapid pre-screening: a validated quality assurance measure in cervical cytology.
Smith J; Nicholas D; Boyd K; Deacon-Smith R
Cytopathology; 2003 Oct; 14(5):275-80. PubMed ID: 14510892
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal trends in cervical cytological lesions and the effect of risk factors. A 30-year overview.
Sigurdsson K; Sigvaldason H
Acta Obstet Gynecol Scand; 2006; 85(3):350-8. PubMed ID: 16553185
[TBL] [Abstract][Full Text] [Related]
39. Uterine cervical neoplasms mass screening at the University Hospital Centre of Libreville, Gabon: Associated factors with precancerous and cancerous lesions.
Woromogo SH; Ambounda Ledaga N; Yagata-Moussa FE; Mihindou AS
PLoS One; 2021; 16(7):e0255289. PubMed ID: 34297784
[TBL] [Abstract][Full Text] [Related]
40. Quality management in gynecologic cytology using interlaboratory comparison.
Jones BA; Davey DD
Arch Pathol Lab Med; 2000 May; 124(5):672-81. PubMed ID: 10782146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
